DK160686A - Tri- og tetracycliske forbindelser - Google Patents

Tri- og tetracycliske forbindelser Download PDF

Info

Publication number
DK160686A
DK160686A DK160686A DK160686A DK160686A DK 160686 A DK160686 A DK 160686A DK 160686 A DK160686 A DK 160686A DK 160686 A DK160686 A DK 160686A DK 160686 A DK160686 A DK 160686A
Authority
DK
Denmark
Prior art keywords
alkyl
phenyl
alkoxy
halogen
hydrogen
Prior art date
Application number
DK160686A
Other languages
English (en)
Other versions
DK168918B1 (da
DK160686D0 (da
Inventor
Hitoshi Uno
Mikio Kurokawa
Fuminori Sato
Naonobu Hatano
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of DK160686A publication Critical patent/DK160686A/da
Publication of DK160686D0 publication Critical patent/DK160686D0/da
Application granted granted Critical
Publication of DK168918B1 publication Critical patent/DK168918B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D337/12—[b,e]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
DK160686A 1984-08-10 1986-04-09 Tri- og tetracycliske forbindelser med en omega-(4-substitueret-1-(homo)piperazinyl)alkanoylaminogruppe, fremgangsmåde til fremstilling af forbindelserne samt præparat indeholdende forbindelserne som aktiv bestanddel DK168918B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP16853284 1984-08-10
JP59168532A JPS6147466A (ja) 1984-08-10 1984-08-10 アミン誘導体
PCT/JP1985/000445 WO1986001203A1 (en) 1984-08-10 1985-08-09 Tryciclic or tetracyclic compounds, process for their preparation, and medicinal composition containing them
JP8500445 1985-08-09

Publications (3)

Publication Number Publication Date
DK160686A true DK160686A (da) 1986-04-09
DK160686D0 DK160686D0 (da) 1986-04-09
DK168918B1 DK168918B1 (da) 1994-07-11

Family

ID=15869764

Family Applications (1)

Application Number Title Priority Date Filing Date
DK160686A DK168918B1 (da) 1984-08-10 1986-04-09 Tri- og tetracycliske forbindelser med en omega-(4-substitueret-1-(homo)piperazinyl)alkanoylaminogruppe, fremgangsmåde til fremstilling af forbindelserne samt præparat indeholdende forbindelserne som aktiv bestanddel

Country Status (11)

Country Link
US (1) US4749703A (da)
EP (1) EP0191867B1 (da)
JP (1) JPS6147466A (da)
KR (1) KR920003198B1 (da)
AT (1) ATE68484T1 (da)
AU (1) AU572690B2 (da)
CA (1) CA1265788A (da)
DE (1) DE3584442D1 (da)
DK (1) DK168918B1 (da)
MX (1) MX9202782A (da)
WO (1) WO1986001203A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8500273D0 (sv) * 1985-01-22 1985-01-22 Leo Ab Nya tricykliska foreningar, kompositioner innehallande sadana foreningar, framstellningsforfaranden och behandlingsmetoder
IL85741A (en) * 1987-03-17 1996-05-14 Hoechst Roussel Pharma Transformed Tetra-Hydroacridines Process for their preparation and pharmaceutical preparations containing A-amino-Tetra-Transformed Hydroacridines
US4882351A (en) * 1987-10-14 1989-11-21 Roussel Uclaf Tricyclic compounds
US4994463A (en) * 1987-12-14 1991-02-19 Kyowa Hakko Kogyo Co., Ltd. Tricyclic thromboxane A2 antagonists
US5242931A (en) * 1988-06-09 1993-09-07 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds as TXA2 antagonists
CA1338625C (en) * 1988-06-09 1996-10-01 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds
CA1340821C (en) * 1988-10-06 1999-11-16 Nobuyuki Fukazawa Heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components
AU655843B2 (en) * 1991-09-24 1995-01-12 Dainippon Pharmaceutical Co. Ltd. Blood lipid metabolism ameliorant
US5643909A (en) * 1993-04-19 1997-07-01 Syntex (U.S.A.) Inc. 10,11-Methanodibenzosuberane derivatives
AU695633B2 (en) * 1995-02-28 1998-08-20 Asubio Pharma Co., Ltd. Arylpiperidine and arylpiperazine derivatives and medicament containing the same
TWI267511B (en) * 1999-06-03 2006-12-01 Lilly Co Eli Process for preparing 10,11-methanobenzosuberane derivatives
BR0306625A (pt) * 2002-05-23 2006-04-18 Abbott Lab acetamidas e benzamidas que são úteis no tratamento de disfunção sexual
EP1611116A2 (en) * 2003-04-08 2006-01-04 Neuromed Technologies, Inc. Calcium channel inhibitors comprising benzhydril spaced from piperazine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB210533A (en) * 1922-11-02 1924-02-04 Reginald Charles Reid Improvements in or relating to apparatus for grinding and polishing lenses and the like
US3954777A (en) * 1970-03-03 1976-05-04 Zambon S.P.A. Aminopropionyl derivatives of 2,3-diphenyl cyclopropylamine
JPS553353B1 (da) * 1971-04-10 1980-01-24
GB1323659A (en) * 1971-04-10 1973-07-18 Yoshitomi Pharmaceutical Piperazine derivatives methods for their production and pharmaceuticl compositions containing them
IT1054961B (it) * 1976-01-23 1981-11-30 Corvi Camillo Spa Derivati della piperazina adatti come agenti anti ulcera
JPS6059177B2 (ja) * 1978-06-24 1985-12-24 日本電信電話株式会社 無水石英ガラスの製造方法
CS210369B1 (cs) * 1980-10-01 1982-01-29 Miroslav Rajsner Nové deriváty 6,11-dihydrodibenzo(b,e)thiepin-5,5-dioxidu, jejich soli a způsob jejich přípravy
ZA825719B (en) * 1981-09-03 1983-06-29 Recordati Chem Pharm Alkanoylanilides
JPS5896075A (ja) * 1981-12-03 1983-06-07 Hokuriku Seiyaku Co Ltd １−アミノカルボニルエチル置換ピペラジン及びホモピペラジン誘導体
US4457931A (en) * 1982-09-27 1984-07-03 Selvi & C. S.P.A. Piperazine derivatives with anticholinergic and/or antihistaminic activity

Also Published As

Publication number Publication date
CA1265788A (en) 1990-02-13
JPS6147466A (ja) 1986-03-07
DE3584442D1 (de) 1991-11-21
DK168918B1 (da) 1994-07-11
JPH0358341B2 (da) 1991-09-05
AU572690B2 (en) 1988-05-12
EP0191867A1 (en) 1986-08-27
US4749703A (en) 1988-06-07
EP0191867A4 (en) 1987-09-02
KR860700251A (ko) 1986-08-01
WO1986001203A1 (en) 1986-02-27
DK160686D0 (da) 1986-04-09
KR920003198B1 (ko) 1992-04-24
EP0191867B1 (en) 1991-10-16
MX9202782A (es) 1992-06-30
AU4721985A (en) 1986-03-07
ATE68484T1 (de) 1991-11-15

Similar Documents

Publication Publication Date Title
DK0389282T3 (da) Xanthinderivater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
YU56192A (sh) Heterociklični derivati
FR2401159A1 (fr) Derives de 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidine-4-one, leur procede de preparation et leur activite therapeutique
RU92004336A (ru) Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты
DK160686A (da) Tri- og tetracycliske forbindelser
FI810604L (fi) Foerfarande foer framstaellning av indanderivat
DK452682A (da) Hidtil ukendte imidazolderivater, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem
ZA9010447B (en) Heterocyclic derivatives,process for their preparation and their therapeutic use
FR2637591B1 (fr) Derives de quinoleinone, leur preparation et leur application en therapeutique
DE3483798D1 (de) Dihydrodibenzocycloheptylidenethylamin-derivate.
ATE21900T1 (de) Pyrimidinonderivate und diese enthaltende pharmazeutische zusammenstellungen.
DE59104469D1 (de) Dialkoxybenzylidenkampfer-Derivate.
PT77666B (fr) Procede de preparation de nouveaux derives de la nitrosouree
ES2043515A1 (es) Procedimiento para la preparacion de nuevos derivados de 1-difenilmetilpiperazina.
FR2539415B1 (fr) Derives de la d-2 imidazoline, leur preparation et leur application en therapeutique
NZ225528A (en) Benzimidazoles substituted in the 2 position by n(4-n-guanidyl) piperidinyl radicals; preparations thereof; pharmaceutical compositions
NO166321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinforbindelser.
ES2070154T3 (es) Derivados de piridoindol y procedimientos para su preparacion.
RU92016209A (ru) Бензофуранилимидазольные производные, способ их получения и терапевтические композиции, содержащие названные производные
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
RU93041059A (ru) 1-азабициклоалкан производные, фармацевтические композиции, их содержащие, и способ их получения
SE8900725L (sv) Indolfoereningar och framstaellning daerav
SE8504708D0 (sv) Novel nucleoside derivatives having antiherpetic properties, pharmaceutical compositions comprising same and process for the preparation of the active ingredients
TH21838A (th) อนุพันธ์ต่างๆของ 1-ออกโซ-2-(เฟนิลซัลโฟนิล อะมิโน)เพนทิลพิเพอริดีน, การเตรียมสารเหล่านี้ และการใช้สารเหล่านี้เกี่ยวกับการรักษาโรค
RU94021690A (ru) Производные бензанилида, способ их получения и фармацевтическая композиция

Legal Events

Date Code Title Description
PBP Patent lapsed
B1 Patent granted (law 1993)
PBP Patent lapsed